Featured Items

The University of Michigan manages the COVID-19 Best Evidence Front Door, a database that assembles meta-analyses, literature syntheses, and clinical guideline documents from multiple highly-reliable sources via a single search.

The DEPRESSD Project is an international collaborative project to maintain a living systematic review on mental health topics related to COVID-19.

The NIH released updated guidelines on July 24th regarding the use of remdesivir to treat COVID-19, based on the results of clinical trials and accounting for limited supply.

The COVID-19 Evidence Network to Support Decision-making (COVID-END) is a comprehensive resource for rapid evidence on the COVID-19 pandemic. The purpose of COVID-END is to encourage cooperation between international evidence synthesis groups and prevent duplication of research effort.

The VA ESP released a new report that critically appraises a study by Daniel E. Freedberg et al. on famotidine use in hospitalized COVID-19 patients. This type of study review provides additional context for the rapidly growing body of evidence related to COVID-19.

A new living rapid review from AHRQ was recently published in Annals of Internal Medicine that provides guidance on the use of different types of masks in community and healthcare settings; the review will be updated monthly.

The VA ESP released an updated rapid response report on corticosteroid therapy for COVID-19 infection to reflect the results from the Randomised Evaluation of COVID-19 Therapy (RECOVERY) study.

The NIH released new guidelines on June 25th regarding the use of dexamethasone for the treatment of patients with COVID-19, based on the results from the Randomised Evaluation of COVID-19 Therapy (RECOVERY) study.